The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Which treatment options impact outcomes in elderly chronic lymphocytic leukemia patients with high prevalence of comorbidity?
Sacha Satram-Hoang
Research Funding - Genentech
Carolina M. Reyes
Employment or Leadership Position - Genentech/Roche
Stock Ownership - Roche
Khang Hoang
Research Funding - Genentech/Roche (I)
Other Remuneration - Genentech (I)
Fayez Momin
No relevant relationships to disclose
Sridhar Guduru
No relevant relationships to disclose
Sandra L. Skettino
Employment or Leadership Position - Genentech
Stock Ownership - Roche